Again, there was no major difference between B cells from SLE patients and those from healthy donors except for the slightly increased response of SLE B cells to the co-stimulation of BCR and TLR9, which was most likely due to the augmented BCR signaling in these cells (Figure 1B). Here, TLR9 is linked to systemic lupus erythematosus.